Senior Medical Science Liaison- Oncology – Lung/GU (Pacific Northwest)

United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a strong scientific background, likely a PharmD, MD, PhD, or equivalent, with a minimum of 3-5 years of experience in medical affairs or a related field within the pharmaceutical industry. Proven experience in oncology, specifically lung or genitourinary cancers, is essential. The role requires excellent communication and presentation skills, the ability to build relationships with key opinion leaders, and a thorough understanding of clinical research, pharmaceutical codes, and regulatory requirements.

Responsibilities

The Senior Medical Science Liaison will disseminate clinical information about Gilead's oncology products to healthcare professionals and key opinion leaders. Responsibilities include responding to clinical inquiries, delivering scientific presentations, implementing medical affairs strategies, and identifying/developing relationships with opinion leaders. The MSL will also train Gilead-approved speakers, serve as a medical resource for commercial teams, participate in advisory boards and conferences, and support clinical research programs by recommending trial sites and collaborating with investigators and internal teams. They will also resolve complex field obstacles and work collaboratively with various internal departments.

Skills

Oncology

Hematology

Clinical Information Dissemination

Scientific Presentations

Promotional Compliance

PhRMA Guidelines

FDA Regulations

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free